Short-term outcomes of a prospective multicenter phase II trial of total neoadjuvant therapy for locally advanced rectal cancer in Japan (ENSEMBLE-1).
Yoshinori KagawaJun WatanabeMamoru UemuraKoji AndoAkira InoueKoji ObaIchiro TakemasaEiji OkiPublished in: Annals of gastroenterological surgery (2023)
ENSEMBLE-1 demonstrated satisfactory pCR and cCR, and well-tolerated safety of TNT for patients with LARC in Japan.